Fire

Listings for an Amazon Echo Sub subwoofer and an Amazon Smart Plug were leaked ahead of a company event on Thursday. The subwoofer is designed to work with Amazon's Echo speakers, which would also get stereo sound functionality, according to the leaked listings on Amazon UK first spotted by the website Pocket-lint. The Amazon Smart Plug would give basic Alexa functionality to devices plugged into it. The devices could become available on October 11, according to Pocket-lint. Two new Amazon devices were leaked on Amazon's UK website ahead of a company event in Seattle on Thursday. The devices, whose listings were first spotted by the website Pocket-lint, are a £75 (about $100) subwoofer called the Echo Sub and a £95 (about $125) smart plug called, well, the Amazon Smart Plug. The Echo Sub is designed to accompany Amazon's Echo and Echo Plus smart speakers for a fuller, deeper sound. Indeed, a subwoofer would add much-needed bass to Amazon's Echo range of smart … [Read more...] about Amazon just accidentally leaked details about 2 new Alexa devices ahead of an event today

In a joint press conference at the White House, President Donald Trump and Poland President Andrzej Duda answer questions about U.S.-EU relations. … [Read more...] about Polish president: No one questions that Trump knows how t…

After three years of trying and failing to attain Olive Garden’s coveted Never Ending Pasta Pass, Jeff Berman finally scored one last year thanks to luck and a solid internet connection. Once he got the $100 card—allowing him to eat as much pasta as he wanted, whenever he wanted over the eight-week Never Ending Pasta Bowl promotion period—he knew he had to do something special. So he started blogging about his adventures, documenting each highly customizable meal, from fettuccine and angel hair alfredo to a makeshift “triple threat” breadstick sandwich stacked with grilled chicken, crispy chicken, crispy shrimp, and sauces. He ate it all with a smile on his face — and became an Olive Garden all-star in the process. “I didn’t even know about the record until I was over halfway through,” Berman, 36, told MONEY. He’s referring to Alan Martin, aka the “Pasta Preacher,” who ate 115 meals straight at the chain in 2014 … [Read more...] about I Bought an Olive Garden Unlimited Pasta Pass and It’s Going to Save Me $10,000. Here’s My Master Plan

REUTERS/Nir Elias Aurora Cannabis is planning for a US initial public offering in October, the company's chief corporate officer said. The Canadian cannabis producer was reportedly in talks with Coca-Cola to make a CBD-infused drink. Marijuana stocks have been red-hot as of late. Watch Aurora Cannabis trade in real time here. Aurora Cannabis, the Canadian cannabis producer that was reportedly in talks with Coca-Cola to make a drink infused with CBD, one of the nonpsychoactive compounds found in cannabis, — that didn't lead to a deal — is targeting a US stock-market debut in October, a report says.  "We're targeting the month of October to establish a US listing," Cam Battley, Aurora's  chief corporate officer, told the Financial Post on Tuesday.  An initial public offering on US markets has become more attractive in recent weeks as cannabis stocks have seen mouthwatering gains. It all started when Canopy Growth received a $4 billion … [Read more...] about The Canadian cannabis producer that was in talks with Coca-Cola to make a CBD-infused drink is reportedly targeting a US IPO in October

By Sunday night, the U.S. Drug Enforcement Administration is expected to reclassify GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)’s Epidiolex to allow medicinal use. This could open the therapy to a new and promising market. The Analyst  Morgan Stanley analyst David Lebowitz maintained an Overweight rating on GW with a $197 price target. The Thesis Morgan Stanley expects the DEA to drop Epidiolex from Schedule I — the same level as cocaine, heroin and other illegal substances — to Schedule IV, where Xanax, Ambien and Tramadol rank. At worst, it would fall to Schedule III alongside moderately to lowly addictive drugs like codeine and anabolic steroids, Lebowitz said. (See his track record here.) Regardless of the assignment, the drug would mark a milestone on the U.S. pharmaceutical timeline. Epidiolex, already the first cannabinoid-based therapy to gain FDA approval, would become the first such drug to launch domestically. The treatment would begin … [Read more...] about Morgan Stanley: DEA Likely To Reclassify GW Pharma’s Cannabinoid Therapy For US Launch